about
Lipids in liver transplant recipients"Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathyDiagnosis, Prognosis, and Therapy of Transthyretin AmyloidosisTherapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis[Obituary for Prof. Dr. Herbert Lochs (1946-2015) ].Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control studyThe plant decapeptide OSIP108 prevents copper-induced apoptosis in yeast and human cellsRisk of venous congestion in live donors of extended right liver graft.MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits.Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose studyEvaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells.Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular CarcinomaIntragenic Deletions in ATP7B as an Unusual Molecular Genetics Mechanism of Wilson's Disease Pathogenesis.Angiotensin II type 1 receptor blockers increase tolerance of cells to copper and cisplatin.Dietary copper triggers onset of fulminant hepatitis in the Long-Evans cinnamon rat model.Editorial: Determinants of Synaptic Information Transfer: From Ca(2+) Binding Proteins to Ca(2+) Signaling Domains.Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy[Extracorporeal liver support of liver failure].Molecular Adsorbent Recirculating System Can Reduce Short-Term Mortality Among Patients With Acute-on-Chronic Liver Failure-A Retrospective Analysis.Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines.Organ-Protective Intensive Care in Organ Donors.The plant decapeptide OSIP108 prevents copper-induced toxicity in various models for Wilson disease.Global epidemiology of transthyretin hereditary amyloid polyneuropathy: a systematic review.Training, work, and lifestyle of transplant physicians and surgeons in Germany.Hepatorenal syndrome: outcome of response to therapy and predictors of survival.Attitudes Concerning Postmortem Organ Donation: A Multicenter Survey in Various German Cohorts.Successful Anti-HCV Therapy of a Former Intravenous Drug User with Sofosbuvir and Daclatasvir in a Peritranspant Setting: A Case Report.Complications after endoscopic sphincterotomy in liver transplant recipients: A retrospective single-centre study.Methanobactin reverses acute liver failure in a rat model of Wilson disease.Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association With Chronic Liver Allograft Failure.Longitudinal analysis of serum miR-122 in a rat model of Wilson's disease.Repeated transplantation of hepatocytes prevents fulminant hepatitis in a rat model of Wilson's disease.Phase 2 open-label extention (OLE) study of patisiran, an investigational siRNA agent for familial amyloidotic polyneuropathy (FAP).Wilson disease mutation pattern with genotype-phenotype correlations from Western India: confirmation of p.C271* as a common Indian mutation and identification of 14 novel mutations.In vitro modelling of familial amyloidotic polyneuropathy allows quantitative detection of transthyretin amyloid fibril-like structures in hepatic derivatives of patient-specific induced pluripotent stem cells.Role of angiotensin-1 receptor blockade in cirrhotic liver resection.FAP plasma-induced cellular toxicity.[Ultrasound of livertransplants].Thermal shift assay for evaluation of transthyretin stability in plasmaEpidemiological and clinical characteristics of persons with transthyretin hereditary amyloid polyneuropathy: a global synthesis of 532 cases
P50
Q26750468-97205688-67C6-4A8D-9A17-6563A91C84BEQ26776343-84C9A2F6-230B-4BA0-B764-405BE6604837Q26776496-67FD3E8B-A596-4746-96BB-0B5D2DCA0FDBQ26782089-69A8482B-5547-46DD-9C73-F224BA07B6C1Q30374417-B18AEEC0-1B52-4080-9275-11801ABAC3A7Q33558782-8C043389-9BE3-4BAA-AB21-D8D0929E20DAQ33709655-0A7B0EA0-E411-4C61-8975-A71747009AFAQ35625451-8037EDE6-55C0-4A72-A42B-97CD3B1CF203Q35671535-93E821FA-2E44-4EBF-8990-077B31E5C2B5Q36025267-38CA26BA-8AEC-448D-BDF3-4E05914C0588Q36120100-7CCDDEF4-ED13-4E38-8EC5-F4B966FC3440Q36137217-9E3072C4-8302-4430-9537-94D369A9881DQ36228224-B4E389D8-28FC-4631-B4A7-F3B6FADDC6B3Q36327667-0FEB76F0-5720-42C1-B08F-AB845121BBC5Q36351891-1F629EB5-64AB-40B9-B017-A9F4716C0165Q36689969-6C6C1090-6807-40DF-810A-4446A2C56ECCQ37420577-F7706AD2-BC50-42C8-AA85-AC09A8E1C9E8Q38432652-FBDA6BF0-4A07-4A6C-9864-2B6EE5589CC5Q38714132-3B5F2DDE-6B7E-47EA-AD8F-A52CF8B56632Q38774848-52F19B89-3BF6-4AC1-BB8D-CB0FA3BA4041Q38947222-1CDE9B8E-2C3A-4084-A58C-19EEDD64F1C9Q38964839-B404470D-BE35-4AD2-A8A9-99DEC9CEE98CQ39257021-1F72312D-2807-4424-BC6D-ACD788A3B73FQ39690124-41F8975B-A8EF-4BB4-915F-7B07E706DF71Q40380997-2C07733B-0385-4876-8061-501B79F9BCFCQ40419402-EC1BF906-6DBB-47D0-BC41-3AF12CDB841EQ40565281-FBAEE982-538E-4F92-813E-F961F1FA9E2FQ40746084-A4174AB3-DDE2-4C32-A38F-38B5B5DF3BA6Q42130897-6B0EECBB-F2FD-4814-BDFC-9A2B7B3038AAQ42160659-98E7FE94-8273-4D83-8FC5-C0DF1E178952Q42226193-DF7E5417-2485-400B-9872-E6B444D9F5AFQ42723129-AB94B6BD-4481-47C4-9BC0-A00DD4F723FEQ45851410-DD35B1E7-F590-4467-B1F1-67FF0C28B170Q46540633-51C93EB6-4507-4D5C-9434-D3C5C35133C2Q48096692-20263E55-D940-450F-B1F9-AA6499CCFF10Q53257065-3122F000-B3E3-4234-AAE7-FE3C51FDBF64Q54156515-DE2B69D6-05AD-4737-B504-970FF60E991CQ54162809-9BF5009A-3A97-4281-BAD1-CFCF84B10B33Q58268287-5409C410-34C2-4AF5-B4AE-12F2F14868B6Q58282970-B2804F47-945B-492F-9DFA-D4147C8DED6B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Hartmut H-J Schmidt
@ast
Hartmut H-J Schmidt
@en
Hartmut H-J Schmidt
@es
Hartmut H-J Schmidt
@nl
Hartmut H-J Schmidt
@sl
type
label
Hartmut H-J Schmidt
@ast
Hartmut H-J Schmidt
@en
Hartmut H-J Schmidt
@es
Hartmut H-J Schmidt
@nl
Hartmut H-J Schmidt
@sl
prefLabel
Hartmut H-J Schmidt
@ast
Hartmut H-J Schmidt
@en
Hartmut H-J Schmidt
@es
Hartmut H-J Schmidt
@nl
Hartmut H-J Schmidt
@sl
P244
P106
P244
n2004121954
P31
P496
0000-0002-2402-7764